| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.53▲ | 10.48▲ | 10.45▲ | 10.32▲ | 10.68▼ |
| MA10 | 10.50▲ | 10.44▲ | 10.57▲ | 10.36▲ | 11.10▼ |
| MA20 | 10.47▲ | 10.58▲ | 10.58▲ | 10.64▼ | 11.78▼ |
| MA50 | 10.41▲ | 10.39▲ | 10.32▲ | 11.47▼ | 10.02▲ |
| MA100 | 10.55▲ | 10.32▲ | 10.52▲ | 11.94▼ | 15.01▼ |
| MA200 | 10.60▲ | 10.55▲ | 10.69▼ | 10.48▲ | 24.53▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | -0.015▼ | -0.027▼ | 0.055▲ | -0.276▼ |
| RSI | 73.336▲ | 55.635▲ | 55.870▲ | 47.369▼ | 45.833▼ |
| STOCH | 81.458▲ | 44.539 | 27.268 | 30.244 | 17.715▼ |
| WILL %R | 0.000▲ | -54.225 | -35.000 | -47.605 | -81.695▼ |
| CCI | 235.687▲ | 39.877 | -17.411 | 28.896 | -78.971 |
| MA | $ARVN Price Crossed Below MA(26) | Set Alert |
|
Tuesday, May 05, 2026 04:23 AM
Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2026 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/05/26 | 10.81 | 10.99 | 10.28 | 10.605 | 603,328 |
| 04/05/26 | 10.02 | 10.94 | 9.85 | 10.78 | 1,418,598 |
| 01/05/26 | 9.75 | 11.40 | 9.73 | 10.51 | 2,147,210 |
| 30/04/26 | 9.95 | 10.08 | 9.74 | 9.90 | 489,005 |
| 29/04/26 | 10.09 | 10.09 | 9.80 | 9.82 | 587,903 |
| 28/04/26 | 10.38 | 10.51 | 10.165 | 10.22 | 428,489 |
| 27/04/26 | 10.42 | 10.79 | 10.22 | 10.29 | 398,638 |
| 24/04/26 | 10.39 | 10.515 | 10.15 | 10.44 | 567,467 |
| 23/04/26 | 10.69 | 10.72 | 10.30 | 10.42 | 524,266 |
| 22/04/26 | 10.70 | 10.735 | 10.515 | 10.63 | 626,172 |
|
|
||||
|
|
||||
|
|